Lawmakers from both parties have introduced new legislation aimed at limiting the influence of pharmacy benefit managers, crucial players in the prescription drug market. They dominate the industry, with the top three firms controlling 80% of prescriptions in the U.S., driving up costs for patients and contributing to the decline of small pharmacies. This bipartisan effort represents an aggressive maneuver to confront the monopolistic behaviors of these conglomerates.
According to Senator Elizabeth Warren, the legislation targets a pervasive issue, stating that pharmacy benefit managers have manipulated the market to enrich themselves. 'They hike up drug costs, cheat employers, and drive small pharmacies out of business,' she said, emphasizing the need for accountability and transparency in the healthcare sector. This assertive legislative push aims to dismantle the overlapping interests that compromise patient care and fair market practices.
#healthcare-legislation #pharmacy-benefit-managers #bipartisan-efforts #drug-pricing #healthcare-conglomerates
Collection
[
|
...
]